Related Experiment Video

Updated: Oct 24, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

[Surgical treatment of coronary insufficiency. Indications and contraindications (author's transl)]

P F Angelino, G G Gensini, G Baduini

    MMW, Munchener Medizinische Wochenschrift
    |September 17, 1976
    PubMed

    Insights

    Aortocoronary bypass surgery is now indicated for more patients due to clinical advancements. Key criteria include affected vessels, artery diameter, and specific heart function measurements, with a 4% mortality rate.

    Area of Science:

    • Cardiovascular Surgery
    • Cardiac Hemodynamics
    • Surgical Indications

    Context:

    • Recent advancements in clinical, hemodynamic, and surgical fields have expanded indications for aortocoronary bypass.
    • Aortocoronary bypass (CABG) is a significant surgical intervention for coronary artery disease.
    • The procedure's safety profile has improved, with current mortality around 4%.

    Purpose:

    • To outline the extended indications for aortocoronary bypass surgery.
    • To detail the critical patient selection criteria for successful surgical outcomes.
    • To provide a concise overview of the current standards for CABG candidacy.

    Summary:

    • Surgical treatment via aortocoronary bypass is now indicated for a broader patient population.
    • Key criteria for patient selection include: multiple affected coronary vessels, artery diameter >1mm below lesion, left ventricular end-diastolic pressure <20 mm Hg, and stroke volume fraction >=0.40.
    • Exclusion criteria include the presence of serious intractable diseases.

    Impact:

    • Facilitates wider application of life-saving aortocoronary bypass procedures.
    • Improves patient selection, potentially leading to better surgical outcomes and reduced mortality.
    • Establishes clear guidelines for clinicians considering surgical intervention for coronary artery disease.

    More Related Videos

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy07:02

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

    Published on: September 9, 2020

    Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

    Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

    Published on: September 15, 2023

    Related Concept Videos

    Cardiac Catheterization I: Pre-Procedure Overview01:28

    Cardiac Catheterization I: Pre-Procedure Overview

    Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Angina II: Classification01:27

    Angina II: Classification

    Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...